ÂÜÀòÂÒÂ×

Bob Broach has extensive work experience in the pharmaceutical and finance industries. Bob is currently working at TG Therapeutics, Inc. as the Director of Market Access Account Management. Prior to this, they were the National Account Director at Oncopeptides AB from October 2020 to November 2021. In 2020, they worked as a Regional Account Manager at Takeda from May to October.

Bob has a long history with Celgene, where they held various roles. Bob was a Senior Market Access Executive responsible for obtaining and maintaining optimal coverage, access, and reimbursement for Celgene's products in the hematology/oncology and inflammation/immunology areas from January 2016 to April 2020. Before this, they served as a Senior Regional Account Manager from May 2010 to December 2015, where they focused on Medicaid and Medicare accounts and negotiated contracts with regional pharmacies. Bob also worked as a Training Account Manager/Interim District Sales Manager from May 2008 to May 2010 and as a Senior Hematology/Oncology Consultant from January 2003 to May 2008.

Prior to their time at Celgene, Bob worked as a Senior Sales Representative at Searle/Pharmacia from June 2000 to December 2002. Bob also served as an Account Manager for Crop Protection at Monsanto Company from May 1996 to May 2000.

Before their career in the pharmaceutical industry, Bob worked as a Bank Examiner at the Federal Reserve Bank of Richmond from January 1991 to April 1994.

Bob Broach has a Bachelor's Degree in Finance/Econ, Cum Laude from James Madison University. Bob also holds a Master of Business Administration (M.B.A.) from William & Mary.